Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Free Realtime Quote CAD

Biosenta Inc. (ZRO.CN)

0.1500
0.0000
(0.00%)
As of April 21 at 3:16:48 PM EDT. Market Open.
Loading Chart for ZRO.CN
  • Previous Close 0.1500
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.1500 - 0.1500
  • 52 Week Range 0.0550 - 0.4900
  • Volume 0
  • Avg. Volume 4,650
  • Market Cap (intraday) 4.924M
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date May 27, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was incorporated in 1986 and is based in Toronto, Canada.

www.biosenta.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZRO.CN

View More

Performance Overview: ZRO.CN

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ZRO.CN
42.31%
S&P/TSX Composite index (^GSPTSE)
0.31%

1-Year Return

ZRO.CN
57.75%
S&P/TSX Composite index (^GSPTSE)
12.91%

3-Year Return

ZRO.CN
57.14%
S&P/TSX Composite index (^GSPTSE)
16.57%

5-Year Return

ZRO.CN
50.00%
S&P/TSX Composite index (^GSPTSE)
71.26%

Compare To: ZRO.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZRO.CN

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    4.92M

  • Enterprise Value

    10.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.79k

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    6.48k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -321.17%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.67k

  • Net Income Avi to Common (ttm)

    -2.34M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.49k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.06M

Research Analysis: ZRO.CN

View More

Company Insights: ZRO.CN

Research Reports: ZRO.CN

View More

People Also Watch